David G Hicks Selected Research

4-trimethylamino-1-butanol (HBTM)

1/2011

Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David G Hicks Research Topics

Disease

55	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2005
42	Neoplasms (Cancer) 03/2022 - 10/2002
7	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2005
7	Carcinoma (Carcinomatosis) 12/2018 - 07/2006
5	Adenocarcinoma 01/2019 - 04/2005
4	Carcinogenesis 01/2015 - 01/2009
3	Pathologic Complete Response 01/2022 - 06/2008
3	Lobular Carcinoma 01/2020 - 10/2010
2	Ductal Carcinoma 01/2016 - 09/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2012 - 01/2009
2	Disease Progression 01/2012 - 01/2005
1	Genomic Instability 10/2017
1	Triple Negative Breast Neoplasms 07/2014
1	Hypoxia (Hypoxemia) 12/2012
1	Arthritis (Polyarthritis) 01/2012
1	Stomach Neoplasms (Stomach Cancer) 12/2011
1	Hypoglycemia (Reactive Hypoglycemia) 10/2009
1	Glioblastoma (Glioblastoma Multiforme) 10/2007
1	Giant Cell Tumors (Giant Cell Tumor) 06/2007
1	Cherubism 06/2007
1	Brain Neoplasms (Brain Tumor) 09/2006
1	Inflammation (Inflammations) 09/2005

Drug/Important Bio-Agent (IBA)

20	Estrogen ReceptorsIBA 01/2022 - 07/2006
17	Proteins (Proteins, Gene)FDA Link 12/2018 - 01/2005
13	human ERBB2 proteinIBA 03/2022 - 09/2006
13	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 11/2006
12	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2006
9	Hormones (Hormone)IBA 01/2019 - 01/2005
8	Trastuzumab (Herceptin)FDA Link 12/2018 - 03/2005
7	Phenobarbital (Luminal)FDA Link 01/2022 - 06/2009
5	ErbB Receptors (EGF Receptor)IBA 01/2021 - 09/2006
4	Biological ProductsIBA 03/2022 - 03/2005
4	Estrogens (Estrogen)FDA Link 01/2021 - 06/2010
4	Coloring Agents (Dyes)IBA 10/2017 - 07/2006
4	ParaffinIBA 03/2015 - 12/2004
3	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 10/2002
3	Indicators and Reagents (Reagents)IBA 01/2016 - 07/2006
3	Formaldehyde (Formol)FDA Link 03/2015 - 05/2010
3	Carrier Proteins (Binding Protein)IBA 01/2015 - 06/2007
3	Androgen Receptors (Androgen Receptor)IBA 08/2014 - 06/2009
3	Monoclonal AntibodiesIBA 01/2012 - 12/2004
3	Keratins (Keratin)IBA 10/2010 - 09/2006
2	Epidermal Growth Factor (EGF)IBA 12/2018 - 04/2005
2	Vitamin E FDA LinkGeneric 01/2015 - 06/2009
2	AntibodiesIBA 03/2010 - 07/2006
2	Small Interfering RNA (siRNA)IBA 06/2007 - 03/2007
2	Messenger RNA (mRNA)IBA 09/2005 - 03/2005
1	Immunoconjugates (Immunoconjugate)IBA 03/2022
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2021
1	StreptavidinIBA 12/2018
1	Carcinoembryonic AntigenIBA 08/2015
1	AntigensIBA 08/2015
1	PhosphoproteinsIBA 03/2015
1	Tocopherols (Tocopherol)IBA 01/2015
1	CateninsIBA 09/2014
1	Cadherins (E-Cadherin)IBA 09/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2014
1	LignansIBA 01/2014
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2014
1	Aromatase InhibitorsIBA 01/2014
1	SteroidsIBA 01/2014
1	Lysine (L-Lysine)FDA Link 12/2012
1	Transcription Factors (Transcription Factor)IBA 11/2012
1	Tyrosine (L-Tyrosine)FDA Link 01/2012
1	AndrogensIBA 01/2012
1	HSP27 Heat-Shock ProteinsIBA 01/2011
1	4-trimethylamino-1-butanol (HBTM)IBA 01/2011
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 10/2009
1	Tamoxifen FDA LinkGeneric 07/2009
1	alpha-Tocopherol FDA Link 06/2009
1	Plasminogen InactivatorsIBA 01/2009
1	Taxoids (Taxanes)IBA 01/2009
1	Plasminogen Activator Inhibitor 1IBA 01/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2008
1	OligonucleotidesIBA 10/2007
1	p38 Mitogen-Activated Protein KinasesIBA 06/2007
1	matrigelIBA 06/2007
1	NFATC Transcription FactorsIBA 06/2007
1	Proto-Oncogene Proteins c-etsIBA 03/2007
1	SilverIBA 03/2007
1	PaxillinIBA 03/2007
1	LuciferasesIBA 03/2007
1	SurvivinIBA 03/2007
1	Keratin-5 (Keratin 5)IBA 09/2006
1	Immune Sera (Antisera)IBA 07/2006
1	PPAR gammaIBA 09/2005
1	AnthracyclinesIBA 04/2005
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2005
1	fascinIBA 01/2005

Therapy/Procedure

22	Therapeutics 03/2022 - 03/2005
7	Drug Therapy (Chemotherapy) 12/2018 - 01/2003
3	Neoadjuvant Therapy 01/2022 - 01/2019
2	Adjuvant Chemotherapy 12/2016 - 03/2010
1	Precision Medicine 11/2019
1	Mammaplasty (Breast Reconstruction) 01/2016
1	Cystectomy 11/2012
1	Mastectomy (Mammectomy) 04/2012
1	Inappropriate Prescribing 08/2009
1	Intravesical Administration 01/2009
1	Aftercare (After-Treatment) 12/2008